Business Segments · Goodwill, Impairment Loss
Pharmaceutical and Specialty Solutions — Goodwill, Impairment Loss
This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ3 2022
Last reportedQ1 2026
How to read this metric
An increase signals poor acquisition performance, strategic missteps, or deteriorating market conditions.
Detailed definition
The charge recognized when the carrying amount of goodwill in the Pharmaceutical and Specialty Solutions segment exceeds...
Peer comparison
Rare for stable industry leaders, but often seen during industry-wide margin compression or strategic pivots.
Metric ID:
cah_segment_pharmaceutical_and_specialty_solutions_goodwill_impairment_lossHistorical Data
9 periods
| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $184.00M |
Range$0.00 – $184.00M
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cardinal Health's pharmaceutical and specialty solutions — goodwill, impairment loss?
- Cardinal Health (CAH) reported pharmaceutical and specialty solutions — goodwill, impairment loss of $184.00M in Q1 2026.
- What does pharmaceutical and specialty solutions — goodwill, impairment loss mean?
- A non-cash charge taken when the value of a previously acquired business is determined to be lower than its recorded book value.